Meridian Bioscience Inc. Stock
Meridian Bioscience Inc. Stock
The community is currently still undecided about Meridian Bioscience Inc. with 1 Buy predictions and 1 Sell predictions.
A target price of 8 € results in a potential of -74.47% which would mean heavy losses compared to the current price of 31.33 € for Meridian Bioscience Inc..
So far the community has only identified positive things for Meridian Bioscience Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Meridian Bioscience Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
M***** P*******
Cons
?
B****
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Meridian Bioscience Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Meridian Bioscience Inc. | - | - | - | - | - | - | - |
| Orthofix Medical Inc. | 0.000% | 6.417% | 28.387% | 6.417% | -22.868% | -43.466% | -69.099% |
| Lantheus Holdings Inc | 1.500% | -3.947% | -8.559% | 43.607% | 53.147% | 15.021% | - |
| Cerus Corp. | -26.800% | -27.907% | -29.545% | 65.187% | 6.164% | -31.315% | -54.187% |
Comments
VivoPower PLC Ordinary Shares (VIVO) is now covered by Noble Financial. They set an "outperform" rating and a $10.00 price target on the stock.
Show more
Ratings data for VIVO provided by MarketBeat
VivoPower PLC Ordinary Shares (VIVO) was downgraded by Wall Street Zen from "hold" to "sell".
Show more
Ratings data for VIVO provided by MarketBeat
News
Icon Q2 Earnings Call Highlights
Key Points
- Interested in Icon Plc? Here are five stocks we like better.
- Icon’s Q2 revenue rose 1.2% year over year to $2.1 billion, while adjusted EBITDA increased to $327.2 million and adjusted
Meridian Q2 Earnings Call Highlights
Key Points
- Interested in Meridian Holdings Inc.? Here are five stocks we like better.
- Meridian delivered stronger financial results: Second-quarter revenue rose 16% year over year to $50.2
Atlas Energy Stock Jumps 39% YTD, but One Fund Cut Exposure by $15 Million Last Quarter
On February 17, 2026, Meridian Wealth Advisors disclosed a reduction in its Atlas Energy Solutions (NYSE:AESI) position, selling 1,458,193 shares for an estimated $14.74 million based on average
